Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/NEWRON-PHARMACEUTICALS-S--198001/news/Newron-Completes-Enrollment-of-Schizophrenia-Patients-in-Potentially-Pivotal-Study-008A-With-Evenami-45649514/?utm_source=whatsapp&utm_medium=social&utm_campaign=share